the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories
Japanese Korean Chinese

[Report]

Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family

Published: 2007/10

Contact 24 hrs/day
Table of Contents

Abstract

Overview

Introduction

Drug targets are the critical link between drugs and their role in the treatment of medical disorders. By grouping drug targets into key protein families, this report provides a comprehensive analysis of the prescription pharmaceutical market by not just molecule type and therapy area, but also by target family.

Scope

  • Classification of the specific drug targets relating to over 650 key products across the PharmaVitae universe
  • Products grouped into major target families, including GPCRs, enzymes, extracellular signalling proteins (ECS), ion channels and nuclear receptors
  • Comprehensive analysis of forecast sales to 2012 by the three fundamental dimensions of pharma space: molecule type, therapy area and target family
  • Discussion of the factors driving the variable performance of different ATC drug classes

Report Highlights

Datamonitor has identified three fundamental dimensions that describe a product' s position within the pharma space-molecule type, therapy area and target type. Analysis of sales across these dimensions reveals key attractiveness characteristics that drive performance

The target type acted on by a product dictates its standing against these key characteristics. Products acting on ECS targets tend to rate most highly and will outperform those acting on other target types. Conversely, products addressing ion channels or nuclear receptors rate poorly and face an overall decline across 2006-12

The arrival of monoclonal antibody and therapeutic protein technologies allowed ECS targets to be exploited, expanding the ' druggable' target space and driving sales growth across 2006-12. Beyond 2012, further technological revolutions will, however, be required if the success experienced by these product classes is to be repeated

Reasons to Purchase

  • Identify product positioning not just in terms of molecule type and therapy area, but also according to target family
  • Rate marketed and pipeline products against the three attractiveness characteristics that determine a product' s likelihood of commercial success
  • Understand the challenges faced by different product groups depending on the targets that they address
Table of Contents

[Report]
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
Published: 2007/10
Published by : Datamonitor Datamonitor

Price:
US $ 7,600.00 PDF by E-mail (Single User License)
>
Product Code : DC57651
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.